Quantcast

Latest Crohn's disease Stories

2014-07-29 16:26:15

Researchers Look to Target Gut Microbiome for Treatment and Prevention of Crohn's Disease and Ulcerative Colitis NEW YORK, July 29, 2014 /PRNewswire/ -- Early findings from a major

2014-07-23 08:27:58

What Will Your Challenge Be? NEW YORK, July 23, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America's endurance training and fundraising program,

CHEM-Grimes-Mohanan-NOD2_Research
2014-07-20 10:59:47

University of Delaware researchers have identified a protein, hiding in plain sight, that acts like a bodyguard to help protect and stabilize another key protein, that when unstable, is involved in Crohn’s disease.

2014-07-18 08:25:11

Take Steps Walk Program Helps Fund Key Initiatives for CCFA NEW YORK, July 18, 2014 /PRNewswire-USNewswire/ -- High-powered research teams supported by

2014-07-16 20:22:34

Local New York team is forming to prepare runners and walkers for the ultimate tour of Vegas NEW YORK, July 16, 2014 /PRNewswire/ -- The 6th annual Rock 'n 'Roll Las Vegas Marathon & 1/2

2014-07-16 12:28:22

Bacteria and Genes in Small Intestine affect course of IBD in Children NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Specific types of bacteria and accompanying gene expression

intestine of a mouse
2014-07-07 05:11:52

Researchers from the University at Buffalo are developing a new imaging technique that could allow doctors to identify and treat gastrointestinal ailments such as irritable bowel syndrome and Crohn’s disease more easily.

2014-07-03 04:21:19

VIENNA, July 3, 2014 /PRNewswire/ -- Debilitating daily symptoms of Inflammatory Bowel Disease (IBD) not only cause depression and psychological complications in young

2014-07-01 23:09:21

Brought to her knees and nearly her death by ulcerative colitis, 25 year old Karin Miller was given a second chance at life thanks to a life-saving surgery.

2014-06-16 12:29:02

DEERFIELD, Ill., and OSAKA, Japan, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced